TY - JOUR T1 - COVID-19: Mechanistic model calibration subject to active and varying non-pharmaceutical interventions JF - medRxiv DO - 10.1101/2020.09.10.20191817 SP - 2020.09.10.20191817 AU - Mark J. Willis AU - Allen Wright AU - Victoria Bramfitt AU - Victor Hugo Grisales Díaz Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/11/2020.09.10.20191817.abstract N2 - Mathematical models are useful in epidemiology to understand the COVID-19 contagion dynamics. Our aim is to demonstrate the effectiveness of parameter regression methods to calibrate an established epidemiological model describing COVID-19 infection rates subject to active and varying non-pharmaceutical interventions (NPIs). To do this, we assess the potential of some established chemical engineering modelling principles and practice for application to modelling of epidemiological systems. This allows us to exploit the sophisticated functionality of a commercial chemical engineering simulator capable of parameter regression with piecewise continuous integration and event and discontinuity management. Our results provide insights into the outcomes of on-going disease suppression measures, while visualisation of reported data also provides up-to-date condition monitoring of the status of the pandemic. We observe that the effective reproduction number response to NPIs is non-linear with variable response rate, magnitude and direction.HighlightsModelling COVID-19 contagion dynamics with piecewise continuous integration and event and discontinuity managementEquivalence to kinetic model with time varying stoichiometryModel calibration and estimation of non-linear variation in ReDevelopment of prototype demonstrator algorithm for estimation of Re using data with time varying NPIsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used to develop models was obtained from public domain sources. https://www.worldometers.info/coronavirus/ ER -